Ditosylate Salt of Itraconazole and Dissolution Enhancement Using Cyclodextrins

Salt formation has been a promising approach for improving the solubility of poorly soluble acidic and basic drugs. The aim of the present study was to prepare the salt form of itraconazole (ITZ), a hydrophobic drug to improve the solubility and hence dissolution performance. Itraconazolium ditolenesulfonate salt (ITZDITOS) was synthesized from ITZ using acid addition reaction with p-toluenesulfonic acid. Salt characterization was performed using 1H NMR, mass spectrometry, Fourier transform infrared spectroscopy, differential scanning calorimetry, and X-ray diffraction. The particle size and morphology was studied using dynamic light scattering technique and scanning electron microscopy, respectively. The solubility of the salt in water and various pharmaceutical solvents was found multifold than ITZ. The dissolution study exhibited 5.5-fold greater percentage release value in 3 h of ITZDITOS (44.53%) as compared with ITZ (8.54%). Results of in vitro antifungal studies using broth microdilution technique indicate that ITZDITOS possessed similar antifungal profile as that of ITZ when tested against four fungal pathogens. Furthermore, the physical mixtures of ITZDITOS with two cyclodextrins, β-cyclodextrin (β-CD), and 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) were prepared in different molar ratios and were evaluated for in vitro release. It was observed that in only 30 min of dissolution study, about 74 and 81% of drug was released from 1:3 molar ratios of ITZDITOS with β-CD and ITZDITOS with HP-β-CD, respectively, which was distinctly higher than the drug released from ITZ commercial capsules (70%). The findings warrant further preclinical and clinical studies on ITZDITOS so that it can be established as an alternative to ITZ for developing oral formulations.

[1]  N. Kumar,et al.  Facile Syntheses of Novel Salts of a Triazole Antifungal Agent with Enhanced Solubility. , 2013 .

[2]  Shishu,et al.  Facile Syntheses of Novel Salts of a Triazole Antifungal Agent with Enhanced Solubility , 2013 .

[3]  C. Cavallari,et al.  Diclofenac salts, part 7: are the pharmaceutical salts with aliphatic amines stable? , 2012, Journal of pharmaceutical sciences.

[4]  C. Strachan,et al.  Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen. , 2011, Molecular pharmaceutics.

[5]  Didem Deliorman Orhan,et al.  Antibacterial, antifungal, and antiviral activities of some flavonoids. , 2010, Microbiological research.

[6]  James W McGinity,et al.  Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion. , 2010, Journal of pharmaceutical sciences.

[7]  Mariarosa Moneghini,et al.  Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology. , 2010, Future medicinal chemistry.

[8]  Chong-K. Kim,et al.  Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release. , 2010, International journal of pharmaceutics.

[9]  Ludo Froyen,et al.  Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[10]  Lynne S. Taylor,et al.  Role of Salt and Excipient Properties on Disproportionation in the Solid-State , 2009, Pharmaceutical Research.

[11]  Lei Wang,et al.  Formulation and stability of itraconazole and odanacatib nanoparticles: governing physical parameters. , 2009, Molecular pharmaceutics.

[12]  B. Zhou,et al.  Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement. , 2009, International journal of pharmaceutics.

[13]  Lokesh Kumar,et al.  Preparation and characterization of salt forms of enalapril. , 2008, Pharmaceutical development and technology.

[14]  Michael B. Bolger,et al.  The composite solubility versus pH profile and its role in intestinal absorption prediction , 2008, AAPS PharmSci.

[15]  F. Dehghani,et al.  Increasing the Dissolution Rate of Itraconazole Processed by Gas Antisolvent Techniques using Polyethylene Glycol as a Carrier , 2008, Pharmaceutical Research.

[16]  R. Sonoda,et al.  Preparation of rapidly disintegrating tablets containing itraconazole solid dispersions. , 2007, Chemical & pharmaceutical bulletin.

[17]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[18]  Siling Wang,et al.  Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization. , 2007, International journal of pharmaceutics.

[19]  K. Johnston,et al.  Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[20]  Chong-K. Kim,et al.  A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Jeong-Sook Park,et al.  Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability , 2005, Archives of pharmacal research.

[22]  Christian Leuner,et al.  Characterization of Solid Dispersions of Itraconazole and Hydroxypropylmethylcellulose Prepared by Melt Extrusion, Part II , 2003, Pharmaceutical Research.

[23]  Yi Tsong,et al.  In Vitro Dissolution Profile Comparison—Statistics and Analysis of the Similarity Factor, f2 , 1998, Pharmaceutical Research.

[24]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[25]  R. Müller,et al.  Intravenous itraconazole emulsions produced by SolEmuls technology. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  Orn Almarsson,et al.  Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. , 2003, Journal of the American Chemical Society.

[27]  J. Keith Guillory,et al.  Handbook of Pharmaceutical Salts: Properties, Selection, and Use Edited by P. Heinrich Stahl and Camile G. Wermuth. VHCA, Verlag Helvetica Chimica Acta, Zürich, Switzerland, and Wiley-VCH, Weinheim, Germany. 2002. vix + 374 pp. 17.5 × 24.5 cm. ISBN 3-906390-26-8. $130.00 , 2003 .

[28]  Lieven Baert,et al.  Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion--Part I. , 2003, International journal of pharmaceutics.

[29]  J. Peeters,et al.  Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7. , 2002, Journal of pharmaceutical sciences.

[30]  Koen Binnemans,et al.  Investigation of thermal properties of glassy itraconazole: identification of a monotropic mesophase , 2001 .

[31]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[32]  M. Ghannoum,et al.  Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents , 2000, Journal of Clinical Microbiology.

[33]  E. Schapoval,et al.  Microbiological assay for terbinafine hydrochloride in tablets and creams. , 2000, International journal of pharmaceutics.

[34]  F. Odds,et al.  Antifungal activity of itraconazole compared with hydroxy-itraconazole in vitro. , 2000, The Journal of antimicrobial chemotherapy.

[35]  K. Chowdary,et al.  Investigation of Dissolution Enhancement of Itraconazole by Solid Dispersion in Superdisintegrants , 2000, Drug development and industrial pharmacy.

[36]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[37]  Bruno C. Hancock,et al.  Characteristics and significance of the amorphous state in pharmaceutical systems. , 1997, Journal of pharmaceutical sciences.

[38]  Joseph T. Rubino,et al.  Solubility, melting point and salting-out relationships in a group of secondary amine hydrochloride salts , 1996 .

[39]  J. W. Moore,et al.  Mathematical comparison of dissolution profiles , 1996 .

[40]  파울 마리빅터길리스,et al.  Beads having a core coated with an antifungal and a polymer , 1993 .

[41]  R. Woestenborghs,et al.  The Clinical Pharmacokinetics of Itraconazole: An Overview , 1989, Mycoses.

[42]  B. Griffith,et al.  Anaphylactoid Reactions Associated with Parenteral Cyclosporine Use: Possible Role of Cremophor EL , 1985, Drug intelligence & clinical pharmacy.

[43]  S Miyazaki,et al.  Precaution on use of hydrochloride salts in pharmaceutical formulation. , 1981, Journal of pharmaceutical sciences.

[44]  Donald C. Monkhouse,et al.  Review ArticlePharmaceutical Salts , 1977 .

[45]  S M Berge,et al.  Pharmaceutical salts. , 1977, Journal of pharmaceutical sciences.

[46]  K. A. Khan.  The concept of dissolution efficiency , 1975, The Journal of pharmacy and pharmacology.